Dopamine D2High receptors on intact cells

Synapse

Volumn 62, Issue 4, 2008, Pages 314-318

  Seeman, Philip ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Anterior pituitary cell; Dopamine D2 receptor; Dopamine D2High receptor; Pituitary cell culture; Prolactin secreting cell; Striatum

Indexed keywords

DOMPERIDONE; DOPAMINE; DOPAMINE 2 RECEPTOR; RACLOPRIDE; SPIPERONE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING SITE; BRAIN HOMOGENATE; BRAIN SLICE; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; HYPOPHYSIS ADENOMA; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA;

ADENOMA; ANIMALS; BINDING, COMPETITIVE; CORPUS STRIATUM; DOMPERIDONE; DOPAMINE ANTAGONISTS; PITUITARY NEOPLASMS; RACLOPRIDE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; SPIPERONE;

EID: 40449143083     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20499     Document Type: Article

References (26)

1. 3H-Domperidone: A selective ligand for dopamine receptors. Naunyn-Schmiedeberg's Arch Pharmacol 308:231-237.
2. Cheng Y, Prusoff WH. 1973. Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 per cent inhibition (150) of an enzymatic reaction. Biochem Pharmacol 22:3099-3108.
3. George SR, Watanabe M, Di Paolo T, Falardeau P, Labrie F, Seeman P. 1985. The functional state of the dopamine receptor in the anterior pituitary is in the high-affinity form. Endocrinology 117:690-697.
4. 11C]raclopride in healthy humans. Human Brain Map 2007 (May 11, Epub ahead of print).
5. 3H]-Domperidone labels only a single population of receptors which convert from high to low affinity for dopamine in rat brain. Naunyn-Schmiedeberg's Arch Pharmacol 332:21-25.
6. Hurbain-Kosmath I, Berault A, Noel N, Polkowska J, Bohin A, Jutisz M, Leiter EH, Beamer WG, Bedigian HG, Davisson MT, Harrison DF. 1990. Gonadotropes in a novel rat pituitary tumor cell line, RC-4B/C. Establishment and partial characterization of the cell line. In Vitro Cell Dev Biol 26:431-440.
7. 3H-domperidone binding and its displacement by dopamine in rat striatal homogenates. J Recept Res 3:163-175.
8. Lee T, Seeman P, Rajput A, Farley IJ, Hornykiewicz O. 1978. Receptor basis for dopaminergic supersensitivity in Parkinson's disease. Nature 273:59-61.
9. Lieberman JA, Kane JM, Alvir J. 1987. Provocative tests with psychostimulant drugs in schizophrenia. Psychopharmacology 91:415-433.
10. Martres MP, Sokoloff P, Schwartz J-C. 1984. Dopaminergic binding sites in rat striatal slices and the action of guanyl nucleotides. Naunyn-Schmiedeberg's Arch Pharmacol 325:116-123.
11. McDonald WM, Sibley DR, Kilpatrick BF, Caron MG. 1984. Dopaminergic inhibition of adenylate cyclase correlates with high affinity agonist binding to anterior pituitary D2 dopamine receptors. Mol Cell Endocrinol 36:201-209.
12. Samaha A-N, Seeman P, Stewart J, Rajabi H, Kapur S. 2007. "Breakthrough" dopamine supersensitivity during ongoing antipsychotic treatment leads to treatment failure over time. J Neurosci 27:2979-2986.
13. Seelig A, Gottschlich R, Devant RM. 1994. A method to determine the ability of drugs to diffuse through the blood-brain barrier. Proc Natl Acad Sci USA 91:68-72.
14. Seeman P. 1982. Nomenclature of central and peripheral dopaminergic sites and receptors. Biochem Pharmacol 31:2563-2568.
15. High receptors. Synapse 61:1013-1018.
16. Seeman P, Bialy HS. 1963. The surface activity of tranquilizers. Biochem Pharmacol 12:1181-1191.
17. 3H-spiperone depend on tissue concentration: analysis and examples. J Neurochem 43:221-235.
18. 3H]spiperone in isotonic medium: Implications for human positron emission tomography. Synapse 49;209-215.
19. High states, implying many paths to psychosis. Proc Natl Acad Sci USA 102:3513-3518.
20. High receptors. Synapse 58:122-128.
21. High dopamine receptors. Synapse 60:319-346.
22. 3H](+)PHNO. Synapse 61:263-267.
23. 3H-domperidone binding sites differ in rat striatum and pituitary. Naunyn-Schmiedeberg's Arch Pharmacol 327:221-227.
24. Sibley DR, De Lean A, Creese I. 1982. Anterior pituitary dopamine receptor. Demonstration of interconvertible high and low affinity states of the D-2 dopamine receptor. J Biol Chem 257:6351-6361.
25. Sibley DR, Mahan LC, Creese I. 1983. Dopamine receptor binding on intact cells. Absence of a high-affinity agonist-receptor binding state. Mol Pharmacol 23:295-302.
26. 11C]-(+)- PHNO positron emission tomography study. Neuropsychopharmacology 2007 (April 4, Epub ahead of print).